Professur für Internistische Rheumatologie, Osteologie und Physikalische Medizin
Präsidium der Justus-Liebig-Universität Gießen » Fachbereiche » Fachbereich 11 - Humanmedizin » Dekanat Fachbereich 11 - Humanmedizin » Zentrum für Innere Medizin
Organisationstyp: Professur
Publikationen 
15 von 72 
15 von 72
- Capillaroscopic features of microangiopathy in rheumatoid arthritis patients with peripheral vascular syndrome (2019)
Lambova, Sevdalina Nikolova; Mueller-Ladner, Ulf - COMPARISON OF IL-17A AND TNF INDUCED CYTOKINE SECRETION BY RHEUMATOID AND PSORIATIC ARTHRITIS SYNOVIAL FIBROBLASTS AND THEIR INHIBITION BY BIOLOGICS (2019)
Frommer, Klaus; Rehart, Stefan; Mueller-Ladner, Ulf; et al. - Dopamine receptor modulation on osteoblast as a potential therapy for arthritis (2019)
Tejedor, L. Salinas; Rickert, M.; Steinmeyer, J.; et al. - DURING ADIPOGENIC DIFFERENTIATION OF MSC ON MINERALIZED BONE FRAGMENTS (2019)
Tsiklauri, Lali; Werner, Janina; Frommer, Klaus; et al. - Effectiveness and safety of anti-tumour necrosis factor therapy with certolizumab pegol observed in real-life rheumatoid arthritis patients in Germany: results from the non-interventional FαsT study (2019)
Burmester, G.; Nuesslein, H.; von Hinueber, U.; et al. - Effect of Biologics on IL-17A and TNF-induced Cytokine Secretion of synovial Fibroblasts in Patients with rheumatoid Arthritis or Psoriatic Arthritis (2019)
Frommer, Klaus; Rehart, Stefan; Mueller-Ladner, Ulf; et al. - EFFECT OF HIGH FAT DIET ON SYSTEMIC AND LOCAL INFLAMMATION IN THE CONTEXT OF OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS MOUSE MODELS (2019)
Sauermilch, H. M.; Huelser, M-L; Schreiyaeck, C.; et al. - Effect of Spleen Tyrosine Kinase (Syk) Inhibitors on synovial Fibroblasts of Patients with rheumatoid Arthritis (2019)
Missimana, Pierrette Lallah; Diller, Magnus; Rehart, Stefan; et al. - EFFECT OF SPLEEN TYROSIN KINASE (SYK)-INHIBITORS ON RHEUMATOID ARTHRITIS SYNOVIAL FIBROBLASTS (2019)
Missimana, Jeanne Pierrette Lallah; Diller, Magnus; Hasseli, Rebecca; et al. - Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study (2019)
Visvanathan, Sudha; Daniluk, Stefan; Ptaszynski, Rafal; et al.
